Georgia Tech engineers have created a pill that could effectively deliver insulin and other injectable drugs, making medicines for chronic illnesses easier for patients to take, less invasive, and potentially less expensive.
It can take as long as 18 months for children with suspected autism spectrum or attention-deficit-hyperactivity disorders to get a diagnostic appointment with a psychiatrist in Indiana. But an interdisciplinary team led by an Indiana University researcher has developed a new diagnostic approach using artificial intelligence that could speed up and improve the detection of neurodivergent disorders.
Liquid biopsies are tests that detect signs of cancer through a simple blood draw. Unlike traditional biopsies, which require removing a piece of tissue, a liquid biopsy typically looks for mutations or modification changes in fragments of DNA from cancer cells circulating in the blood.
Glucotrack, which is developing a glucose monitor that is implanted through a minimally invasive surgery, said the small study met safety and performance goals.
Regulatory milestone paves the way for expanded access to Morphic’s non-implant, incisionless solution for treating acid reflux and related gastrointestinal disorders across Europe.
Mendaera has received FDA 510(k) clearance for its Focalist handheld robotic system, which enhances the precision of ultrasound-guided needle placement across multiple specialties.
FREMONT, Calif., July 8, 2025 /PRNewswire/ — Q’Apel Medical (Q’Apel), a private medical device company focused on revolutionizing neurovascular interventions, today announced it has received U.S. Food and Drug Administration (FDA) clearance for its Zebra Neurovascular Access System. Available in 6F and 7F sizes, Zebra is indicated for the introduction of interventional devices into the peripheral and neurovasculature.
In combat zones and emergency rescues, rapid evacuation and treatment can mean the difference between life and death. But prolonged immobilization during transport poses another life-threatening risk: pressure injuries.
A Loughborough University student has developed a new medical device that could transform how prostate health is assessed and monitored.
For over a century, surgeons performing delicate procedures have relied on stereoscopic microscopes to gain a sense of depth. These tools mimic human vision by presenting slightly different images to each eye, allowing the brain to perceive three-dimensional structures—a crucial aid when working with fragile blood vessels or intricate brain tissue. Despite modern upgrades like digital displays and video capture, today’s operating microscopes still depend on the same core principle: two views, interpreted by the human brain.